Your session is about to expire
← Back to Search
Behavioral Intervention
Positive Psychology for Post-Bariatric Surgery Patients
N/A
Recruiting
Led By Larissa McGarrity, PhD
Research Sponsored by Larissa McGarrity, Ph.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week #16
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a positive psychology intervention for patients who had bariatric surgery and their partners. The study wants to see if the intervention can improve depressive symptoms, resilience, relationship satisfaction, eating
Who is the study for?
This trial is for adult couples where one partner had bariatric surgery (Roux-en-Y gastric bypass or sleeve gastrectomy) 1-3 years ago at the participating institution. They must be cohabiting, in a romantic relationship since before the surgery, and both willing to enroll in the study.
What is being tested?
The trial tests 'ReConnect', a remote positive psychology program designed for post-bariatric surgery patients and their partners. It checks if this 8-week intervention can improve depression, resilience, satisfaction in relationships, healthy behaviors, and weight maintenance compared to those on a waitlist.
What are the potential side effects?
Since 'ReConnect' is a psychological intervention rather than a medical treatment, it may not have typical side effects. However, participants might experience emotional discomfort or increased interpersonal tension as they engage with personal topics during sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week #16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week #16
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Depressive Symptoms
Secondary study objectives
Eating Behaviors
Physical Activity
Relationship Satisfaction
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Waitlist Control ConditionExperimental Treatment1 Intervention
Participants will receive 8 weeks of check-in surveys/follow-ups followed by 8 weeks of ReConnect, as well as 3 assessments (baseline, 8 weeks, 16 weeks).
Group II: Intervention ConditionExperimental Treatment1 Intervention
Participants will receive 8 weeks of ReConnect followed by 8 weeks check-in surveys/follow-ups, as well as 3 assessments (baseline, 8 weeks, 16 weeks).
Find a Location
Who is running the clinical trial?
Larissa McGarrity, Ph.D.Lead Sponsor
Larissa McGarrity, PhDPrincipal InvestigatorUniversity of Utah Craig Neilsen H. Rehabilitation Hospital
Share this study with friends
Copy Link
Messenger